Highlights

  • SII seeks drug regulator's nod for booster dose
  • Covovax use a heterologous dose
  • Vaccine will be administered to all adults already vaccinated

Latest news

Russian missile barrage on Kyiv kills one, damages diplomatic missions

Russian missile barrage on Kyiv kills one, damages diplomatic missions

2,200 cases of violence against Hindus, other minorities in Bangladesh: Govt

2,200 cases of violence against Hindus, other minorities in Bangladesh: Govt

Holiday special train begins on UNESCO world heritage Shimla-Kalka railway line

Holiday special train begins on UNESCO world heritage Shimla-Kalka railway line

Poco M7 Pro 5G Review: Best Budget champ? Check Pros and Cons

Poco M7 Pro 5G Review: Best Budget champ? Check Pros and Cons

Parliament's session ends amid deepening political animosity, records low productivity

Parliament's session ends amid deepening political animosity, records low productivity

Indian Stock Market Indices: Sector Analysis Performance Today - 20 December, 2024

Indian Stock Market Indices: Sector Analysis Performance Today - 20 December, 2024

Global Stock Market Indices: How the World Markets Performed Today - 20 December, 2024

Global Stock Market Indices: How the World Markets Performed Today - 20 December, 2024

NSE Nifty 50 Top Gainers: What are the 5 Biggest Stock Gainers Today (Dec 20)?

NSE Nifty 50 Top Gainers: What are the 5 Biggest Stock Gainers Today (Dec 20)?

Serum Institute seeks approval for market authorisation of its booster dose: reports

Once approved, Covovax will be administered to all adults who have already taken two doses of Covishield or Covaxin, according to reports

Serum Institute seeks approval for market authorisation of its booster dose: reports

The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its Covid-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday.

Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for the heterologous booster dose of Covovax to the drugs controller general of India (DCGI) on October 17.

It has been learnt that the DCGI's office had raised a few queries, after which Singh submitted a reply, mentioning about the current emerging situation caused by a new coronavirus variant.

Also watch: Twitter ends enforcement of Covid misinformation policy

Covovax was approved by the DCGI for a restricted emergency use in children aged seven to 11 years in June.

The DCGI had approved Covovax for a restricted use in emergency situations in adults on December 28, 2021 and for those in the 12-17 age group, subject to certain conditions, on March 9.

Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorisation.

It was granted emergency-use listing by the World Health Organization (WHO) on December 2017, 2020. In August 2020, US-based vaccine maker Novavax Inc. had announced a licence agreement with the SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in India and low-and-middle-income countries

ADVERTISEMENT

Up Next

Serum Institute seeks approval for market authorisation of its booster dose: reports

Serum Institute seeks approval for market authorisation of its booster dose: reports

2,200 cases of violence against Hindus, other minorities in Bangladesh: Govt

2,200 cases of violence against Hindus, other minorities in Bangladesh: Govt

Holiday special train begins on UNESCO world heritage Shimla-Kalka railway line

Holiday special train begins on UNESCO world heritage Shimla-Kalka railway line

11 dead, over 35 injured in fire after LPG tanker crashes on Jaipur-Ajmer highway

11 dead, over 35 injured in fire after LPG tanker crashes on Jaipur-Ajmer highway

Parliament's session ends amid deepening political animosity, records low productivity

Parliament's session ends amid deepening political animosity, records low productivity

Parliament Winter Session: Lok Sabha saw 57.87 per cent productivity

Parliament Winter Session: Lok Sabha saw 57.87 per cent productivity

ADVERTISEMENT

editorji-whatsApp

More videos

Punjab govt reaffirms commitment to safeguarding farmers' rights under national agricultural policy

Punjab govt reaffirms commitment to safeguarding farmers' rights under national agricultural policy

Punjab to close Bist Doab Canal for 33 days

Punjab to close Bist Doab Canal for 33 days

Punjab: 21st December declared as a 'close day' within the jurisdiction of the municipal bodies

Punjab: 21st December declared as a 'close day' within the jurisdiction of the municipal bodies

Former Haryana CM Om Prakash Chautala passes away at 89

Former Haryana CM Om Prakash Chautala passes away at 89

Airtel, CtrlS, and Holoware Submit Major Investment Proposals in Bihar's IT Sector

Airtel, CtrlS, and Holoware Submit Major Investment Proposals in Bihar's IT Sector

Maha Kumbh 2025: Prayagraj Mela administration hikes boat fare by 50 pc

Maha Kumbh 2025: Prayagraj Mela administration hikes boat fare by 50 pc

DND flyway to remain toll-free, says Supreme Court

DND flyway to remain toll-free, says Supreme Court

Parliament Winter Session 2024: Rajya Sabha adjourns sine die

Parliament Winter Session 2024: Rajya Sabha adjourns sine die

Several Delhi schools receive bomb-threat mail, no suspicious items found

Several Delhi schools receive bomb-threat mail, no suspicious items found

PM Modi celebrates Christmas at George Kurian's residence in Delhi

PM Modi celebrates Christmas at George Kurian's residence in Delhi

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.